<DOC>
	<DOC>NCT02128191</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of no treatment compared with ibuprofen treatment for patent ductus arteriosus in preterm infants. The study hypothesis is that no treatment is not inferior to oral ibuprofen treatment in preterm infants. (non-inferiority study)</brief_summary>
	<brief_title>No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants</brief_title>
	<detailed_description>This study is a randomized, double-blind, placebo-controlled, non-inferiority clinical trial.</detailed_description>
	<mesh_term>Ductus Arteriosus, Patent</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1. gestational age of 30 weeks or less or birth weight of 1250 g or less 2. born in Samsung Medical Center 3. confirmed to have hemodynamically significant patent ductus arteriosus (PDA) during day of life (DOL) 5 to 14 4. Definition of hemodynamically significant PDA: at least one of clinical criteria plus at least one of echocardiographic criteria Clinical criteria Respiratory signs, including tachypnea, chest retraction, increased respiratory support, unable to wean respiratory support Physical signs, including a murmur, hyperdynamic precordium or bounding pulses Blood pressure problems, including decreased mean or diastolic pressure or increased pulse pressure Signs of congestive heart failure, including cardiomegaly, hepatomegaly or pulmonary congestion Echocardiographic criteria Ductal size ≥ 1.5 mm left atrium (LA)/Aorta ratio ≥1.5:1 Lefttoright shunting or bidirectional shunting with dominant lefttoright blood flow (the presence of a color jet in the mean pulmonary artery) Mortality within the first 48 hours of life Righttoleft shunt or bidirectional shunting with dominant righttoleft shunt through PDA congenital anomaly bilateral intraventricular hemorrhage of grade 4 contraindication of ibuprofen (bleeding diasthesis, platelet count 10,000/mm3 or less, serum creatinine 2.0 mg/dL or greater, necrotizing enterocolitis stage 2 or greater</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Patent ductus arteriosus</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Bronchopulmonary dysplasia</keyword>
</DOC>